Craft

Apertura Gene Therapy

Total Funding

$67 M

Apertura Gene Therapy Summary

Company Summary

Overview
Apertura Gene Therapy is a biotech company creating technology for treating debilitating diseases with limited options for patients. It specializes in developing genetic medicines to solve limitations in cellular access, gene expression, pre-existing immunity, and manufacturability.
Type
Private
Status
Active
Founded
2021
HQ
New York, NY, US | view all locations
Website
https://aperturagtx.com/
Cybersecurity rating
Sectors

Key People

  • David Greenwald
  • Andrew Steinsapir
  • Kristina Wang

    Kristina Wang, Director of Corporate Development

LocationsView all

1 location detected

  • New York, NY HQ

    United States

    345 Park Ave S

Footer menu